CIK 0001020214 · Accelerated filer
CERUS CORP
Sign in to watch- Ticker
- CERS
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 680262011
- Phone
- 9252886000
- Business address
- 1220 CONCORD AVENUE, SUITE 600, CONCORD, CA, 94520
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $89,529
- in 1 filing, $90K under 10b5-1 plans
Net −$89,529. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-03-12 | Menard Chrystal Chief Legal Officer | Option exercise | +16,667 | 355,288 | ||
| 2023-03-12 | Menard Chrystal Chief Legal Officer | Option exercise · Restricted Stock Unit | −23,460 | 0 | ||
| 2023-03-12 | Menard Chrystal Chief Legal Officer | Option exercise · Restricted Stock Unit | −16,667 | 16,666 | ||
| 2023-03-12 | Greenman William Mariner President and CEO | Option exercise | +107,525 | 2,654,159 | ||
| 2023-03-12 | Greenman William Mariner President and CEO | Option exercise | +64,667 | 2,681,078 | ||
| 2023-03-12 | Greenman William Mariner President and CEO | Option exercise · Restricted Stock Unit | −107,525 | 0 | ||
| 2023-03-12 | Greenman William Mariner President and CEO | Option exercise · Restricted Stock Unit | −64,667 | 64,666 | ||
| 2023-03-12 | Green Kevin Dennis Chief Financial Officer | Option exercise | +23,460 | 431,459 | ||
| 2023-03-12 | Green Kevin Dennis Chief Financial Officer | Option exercise | +21,667 | 443,464 | ||
| 2023-03-12 | Green Kevin Dennis Chief Financial Officer | Option exercise · Restricted Stock Unit | −23,460 | 0 | ||
| 2023-03-12 | Green Kevin Dennis Chief Financial Officer | Option exercise · Restricted Stock Unit | −21,667 | 21,666 | ||
| 2023-03-12 | CORASH LAURENCE M Chief Scientific Officer | Option exercise | +23,460 | 2,260,176 | ||
| 2023-03-12 | CORASH LAURENCE M Chief Scientific Officer | Option exercise | +16,667 | 2,267,246 | ||
| 2023-03-12 | CORASH LAURENCE M Chief Scientific Officer | Option exercise · Restricted Stock Unit | −23,460 | 0 | ||
| 2023-03-12 | CORASH LAURENCE M Chief Scientific Officer | Option exercise · Restricted Stock Unit | −16,667 | 16,666 | ||
| 2023-03-12 | Benjamin Richard J Chief Medical Officer | Option exercise | +23,460 | 356,125 | ||
| 2023-03-12 | Benjamin Richard J Chief Medical Officer | Option exercise | +16,667 | 363,186 | ||
| 2023-03-12 | Benjamin Richard J Chief Medical Officer | Option exercise · Restricted Stock Unit | −23,460 | 0 | ||
| 2023-03-12 | Benjamin Richard J Chief Medical Officer | Option exercise · Restricted Stock Unit | −16,667 | 16,666 | ||
| 2023-03-01 | Moore Carol SVP Reg. & Quality | Grant or award | +110,000 | 393,866 |
Page 11 of 27 · 524 trades